<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33767386</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>25</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>Efficacy and long-term safety of CRISPR/Cas9 genome editing in the SOD1-linked mouse models of ALS.</ArticleTitle><Pagination><StartPage>396</StartPage><MedlinePgn>396</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">396</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-021-01942-4</ELocationID><Abstract><AbstractText>CRISPR/Cas9-mediated genome editing provides potential for therapeutic development. Efficacy and long-term safety represent major concerns that remain to be adequately addressed in preclinical studies. Here we show that CRISPR/Cas9-mediated genome editing in two distinct SOD1-amyotrophic lateral sclerosis (ALS) transgenic mouse models prevented the development of ALS-like disease and pathology. The disease-linked transgene was effectively edited, with rare off-target editing events. We observed frequent large DNA deletions, ranging from a few hundred to several thousand base pairs. We determined that these large deletions were mediated by proximate identical sequences in Alu elements. No evidence of other diseases was observed beyond 2 years of age in these genome edited mice. Our data provide preclinical evidence of the efficacy and long-term safety of the CRISPR/Cas9 therapeutic approach. Moreover, the molecular mechanism of proximate identical sequences-mediated recombination provides mechanistic information to optimize therapeutic targeting design, and to avoid or minimize unintended and potentially deleterious recombination events.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Han-Xiang</ForeName><Initials>HX</Initials><Identifier Source="ORCID">0000-0002-0030-8465</Identifier><AffiliationInfo><Affiliation>The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. h-deng@northwestern.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhai</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Guoxiang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowry</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>&#xc9;anna B</ForeName><Initials>&#xc9;B</Initials><AffiliationInfo><Affiliation>The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Jianhua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Nigel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhihua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Erdong</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yongchao C</ForeName><Initials>YC</Initials><Identifier Source="ORCID">0000-0002-2469-4356</Identifier><AffiliationInfo><Affiliation>Departments of Pediatrics, Neurology and Physiology, Ann &amp; Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siddique</LastName><ForeName>Teepu</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7293-9146</Identifier><AffiliationInfo><Affiliation>The Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. t-siddique@northwestern.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS099623</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS099638</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS118928</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064113" MajorTopicYN="N">CRISPR-Cas Systems</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072669" MajorTopicYN="N">Gene Editing</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33767386</ArticleId><ArticleId IdType="pmc">PMC7994668</ArticleId><ArticleId IdType="doi">10.1038/s42003-021-01942-4</ArticleId><ArticleId IdType="pii">10.1038/s42003-021-01942-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rosen DR, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 1993;261:1047&#x2013;1051. doi: 10.1126/science.8351519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8351519</ArticleId><ArticleId IdType="pubmed">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase. Neurology. 1997;48:55&#x2013;57. doi: 10.1212/WNL.48.1.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.48.1.55</ArticleId><ArticleId IdType="pubmed">9008494</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1774. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc. Natl Acad. Sci. USA. 2006;103:7142&#x2013;7147. doi: 10.1073/pnas.0602046103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0602046103</ArticleId><ArticleId IdType="pmc">PMC1447523</ArticleId><ArticleId IdType="pubmed">16636275</ArticleId></ArticleIdList></Reference><Reference><Citation>Reaume AG, et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 1996;13:43&#x2013;47. doi: 10.1038/ng0596-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0596-43</ArticleId><ArticleId IdType="pubmed">8673102</ArticleId></ArticleIdList></Reference><Reference><Citation>Jinek M, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337:816&#x2013;821. doi: 10.1126/science.1225829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1225829</ArticleId><ArticleId IdType="pmc">PMC6286148</ArticleId><ArticleId IdType="pubmed">22745249</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong L, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339:819&#x2013;823. doi: 10.1126/science.1231143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1231143</ArticleId><ArticleId IdType="pmc">PMC3795411</ArticleId><ArticleId IdType="pubmed">23287718</ArticleId></ArticleIdList></Reference><Reference><Citation>Mali P, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339:823&#x2013;826. doi: 10.1126/science.1232033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232033</ArticleId><ArticleId IdType="pmc">PMC3712628</ArticleId><ArticleId IdType="pubmed">23287722</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 2013;31:822&#x2013;826. doi: 10.1038/nbt.2623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2623</ArticleId><ArticleId IdType="pmc">PMC3773023</ArticleId><ArticleId IdType="pubmed">23792628</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin HY, et al. CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome. Nat. Commun. 2017;8:15464. doi: 10.1038/ncomms15464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15464</ArticleId><ArticleId IdType="pmc">PMC5460021</ArticleId><ArticleId IdType="pubmed">28561021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosicki M, Tomberg K, Bradley A. Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 2018;36:765&#x2013;771. doi: 10.1038/nbt.4192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.4192</ArticleId><ArticleId IdType="pmc">PMC6390938</ArticleId><ArticleId IdType="pubmed">30010673</ArticleId></ArticleIdList></Reference><Reference><Citation>Pineda M, Lear A, Collins JP, Kiani S. Safe CRISPR: challenges and possible solutions. Trends Biotechnol. 2019;37:389&#x2013;401. doi: 10.1016/j.tibtech.2018.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibtech.2018.09.010</ArticleId><ArticleId IdType="pubmed">30352704</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, et al. Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell. 2013;13:659&#x2013;662. doi: 10.1016/j.stem.2013.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2013.10.016</ArticleId><ArticleId IdType="pubmed">24315440</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin H, et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 2014;32:551&#x2013;553. doi: 10.1038/nbt.2884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2884</ArticleId><ArticleId IdType="pmc">PMC4157757</ArticleId><ArticleId IdType="pubmed">24681508</ArticleId></ArticleIdList></Reference><Reference><Citation>Long C, et al. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science. 2016;351:400&#x2013;403. doi: 10.1126/science.aad5725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad5725</ArticleId><ArticleId IdType="pmc">PMC4760628</ArticleId><ArticleId IdType="pubmed">26721683</ArticleId></ArticleIdList></Reference><Reference><Citation>Long C, et al. Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA. Science. 2014;345:1184&#x2013;1188. doi: 10.1126/science.1254445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254445</ArticleId><ArticleId IdType="pmc">PMC4398027</ArticleId><ArticleId IdType="pubmed">25123483</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, et al. A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice. Nat. Biotechnol. 2016;34:334&#x2013;338. doi: 10.1038/nbt.3469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3469</ArticleId><ArticleId IdType="pmc">PMC4786489</ArticleId><ArticleId IdType="pubmed">26829317</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu W, et al. Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice. Nat. Commun. 2017;8:14716. doi: 10.1038/ncomms14716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14716</ArticleId><ArticleId IdType="pmc">PMC5355895</ArticleId><ArticleId IdType="pubmed">28291770</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, et al. CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington&#x2019;s disease. J. Clin. Investig. 2017;127:2719&#x2013;2724. doi: 10.1172/JCI92087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI92087</ArticleId><ArticleId IdType="pmc">PMC5490741</ArticleId><ArticleId IdType="pubmed">28628038</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H, et al. In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer&#x2019;s disease. Nat. Neurosci. 2019;22:524&#x2013;528. doi: 10.1038/s41593-019-0352-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0352-0</ArticleId><ArticleId IdType="pubmed">30858603</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Lau YS, Gao Y, Li H, Han R. Life-long AAV-mediated CRISPR genome editing in dystrophic heart improves cardiomyopathy without causing serious lesions in mdx mice. Mol. Ther. 2019;27:1407&#x2013;1414. doi: 10.1016/j.ymthe.2019.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2019.05.001</ArticleId><ArticleId IdType="pmc">PMC6697345</ArticleId><ArticleId IdType="pubmed">31129119</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaj T, et al. In vivo genome editing improves motor function and extends survival in a mouse model of ALS. Sci. Adv. 2017;3:eaar3952. doi: 10.1126/sciadv.aar3952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aar3952</ArticleId><ArticleId IdType="pmc">PMC5738228</ArticleId><ArticleId IdType="pubmed">29279867</ArticleId></ArticleIdList></Reference><Reference><Citation>Donehower LA, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992;356:215&#x2013;221. doi: 10.1038/356215a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/356215a0</ArticleId><ArticleId IdType="pubmed">1552940</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz SF, et al. Disruption of Trp53 in livers of mice induces formation of carcinomas with bilineal differentiation. Gastroenterology. 2012;142:e1223. doi: 10.1053/j.gastro.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2012.02.009</ArticleId><ArticleId IdType="pubmed">22342966</ArticleId></ArticleIdList></Reference><Reference><Citation>Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 1991;108:193&#x2013;199. doi: 10.1016/0378-1119(91)90434-D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0378-1119(91)90434-D</ArticleId><ArticleId IdType="pubmed">1660837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 2010;79:181&#x2013;211. doi: 10.1146/annurev.biochem.052308.093131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.052308.093131</ArticleId><ArticleId IdType="pmc">PMC3079308</ArticleId><ArticleId IdType="pubmed">20192759</ArticleId></ArticleIdList></Reference><Reference><Citation>McVey M, Lee SE. MMEJ repair of double-strand breaks (director&#x2019;s cut): deleted sequences and alternative endings. Trends Genet. 2008;24:529&#x2013;538. doi: 10.1016/j.tig.2008.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2008.08.007</ArticleId><ArticleId IdType="pmc">PMC5303623</ArticleId><ArticleId IdType="pubmed">18809224</ArticleId></ArticleIdList></Reference><Reference><Citation>Haber JE. A life investigating pathways that repair broken chromosomes. Annu Rev. Genet. 2016;50:1&#x2013;28. doi: 10.1146/annurev-genet-120215-035043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genet-120215-035043</ArticleId><ArticleId IdType="pubmed">27732795</ArticleId></ArticleIdList></Reference><Reference><Citation>Mali P, et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 2013;31:833&#x2013;838. doi: 10.1038/nbt.2675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2675</ArticleId><ArticleId IdType="pmc">PMC3818127</ArticleId><ArticleId IdType="pubmed">23907171</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu PD, et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 2013;31:827&#x2013;832. doi: 10.1038/nbt.2647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2647</ArticleId><ArticleId IdType="pmc">PMC3969858</ArticleId><ArticleId IdType="pubmed">23873081</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattanayak V, et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol. 2013;31:839&#x2013;843. doi: 10.1038/nbt.2673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2673</ArticleId><ArticleId IdType="pmc">PMC3782611</ArticleId><ArticleId IdType="pubmed">23934178</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 2013;31:233&#x2013;239. doi: 10.1038/nbt.2508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2508</ArticleId><ArticleId IdType="pmc">PMC3748948</ArticleId><ArticleId IdType="pubmed">23360965</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhargava R, Onyango DO, Stark JM. Regulation of single-strand annealing and its role in genome maintenance. Trends Genet. 2016;32:566&#x2013;575. doi: 10.1016/j.tig.2016.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2016.06.007</ArticleId><ArticleId IdType="pmc">PMC4992407</ArticleId><ArticleId IdType="pubmed">27450436</ArticleId></ArticleIdList></Reference><Reference><Citation>Notini AJ, Li R, Western PS, Sinclair AH, White SJ. Rapid and reliable determination of transgene zygosity in mice by multiplex ligation-dependent probe amplification. Transgenic Res. 2009;18:987&#x2013;991. doi: 10.1007/s11248-009-9284-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11248-009-9284-x</ArticleId><ArticleId IdType="pubmed">19504348</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, et al. Large genomic fragment deletions and insertions in mouse using CRISPR/Cas9. PLoS ONE. 2015;10:e0120396. doi: 10.1371/journal.pone.0120396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0120396</ArticleId><ArticleId IdType="pmc">PMC4372442</ArticleId><ArticleId IdType="pubmed">25803037</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito Y, et al. Transgenic small interfering RNA halts amyotrophic lateral sclerosis in a mouse model. J. Biol. Chem. 2005;280:42826&#x2013;42830. doi: 10.1074/jbc.M507685200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M507685200</ArticleId><ArticleId IdType="pubmed">16221675</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller TM, et al. Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis. Ann. Neurol. 2005;57:773&#x2013;776. doi: 10.1002/ana.20453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20453</ArticleId><ArticleId IdType="pmc">PMC1351126</ArticleId><ArticleId IdType="pubmed">15852369</ArticleId></ArticleIdList></Reference><Reference><Citation>Foust KD, et al. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. Mol. Ther. 2013;21:2148&#x2013;2159. doi: 10.1038/mt.2013.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2013.211</ArticleId><ArticleId IdType="pmc">PMC3863799</ArticleId><ArticleId IdType="pubmed">24008656</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, et al. Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis. Hum. Mol. Genet. 2014;23:668&#x2013;681. doi: 10.1093/hmg/ddt454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt454</ArticleId><ArticleId IdType="pmc">PMC3888258</ArticleId><ArticleId IdType="pubmed">24108104</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica L, et al. Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model. Ann. Neurol. 2016;79:687&#x2013;700. doi: 10.1002/ana.24618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24618</ArticleId><ArticleId IdType="pmc">PMC5374859</ArticleId><ArticleId IdType="pubmed">26891182</ArticleId></ArticleIdList></Reference><Reference><Citation>McCampbell A, et al. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J. Clin. Investig. 2018;128:3558&#x2013;3567. doi: 10.1172/JCI99081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI99081</ArticleId><ArticleId IdType="pmc">PMC6063493</ArticleId><ArticleId IdType="pubmed">30010620</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim CKW, et al. Treatment of a mouse model of ALS by in vivo base editing. Mol. Ther. 2020;28:1177&#x2013;1189. doi: 10.1016/j.ymthe.2020.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2020.01.005</ArticleId><ArticleId IdType="pmc">PMC7132599</ArticleId><ArticleId IdType="pubmed">31991108</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C, et al. SOD1 suppression with adeno-associated virus and MicroRNA in familial ALS. N. Engl. J. Med. 2020;383:151&#x2013;158. doi: 10.1056/NEJMoa2005056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2005056</ArticleId><ArticleId IdType="pubmed">32640133</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T, et al. Phase 1-2 trial of antisense oligonucleotide tofersen for SOD1 ALS. N. Engl. J. Med. 2020;383:109&#x2013;119. doi: 10.1056/NEJMoa2003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Roy S. Gene-based therapies for neurodegenerative diseases. Nat. Neurosci. 2021;24:297&#x2013;311. doi: 10.1038/s41593-020-00778-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00778-1</ArticleId><ArticleId IdType="pubmed">33526943</ArticleId></ArticleIdList></Reference><Reference><Citation>Scully R, Panday A, Elango R, Willis NA. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nat. Rev. Mol. Cell Biol. 2019;20:698&#x2013;714. doi: 10.1038/s41580-019-0152-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0152-0</ArticleId><ArticleId IdType="pmc">PMC7315405</ArticleId><ArticleId IdType="pubmed">31263220</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyama T, Wilson DM. DNA repair mechanisms in dividing and non-dividing cells. DNA Repair. 2013;12:620&#x2013;636. doi: 10.1016/j.dnarep.2013.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2013.04.015</ArticleId><ArticleId IdType="pmc">PMC3720834</ArticleId><ArticleId IdType="pubmed">23684800</ArticleId></ArticleIdList></Reference><Reference><Citation>Lander ES, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860&#x2013;921. doi: 10.1038/35057062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35057062</ArticleId><ArticleId IdType="pubmed">11237011</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae S, Park J, Kim JS. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics. 2014;30:1473&#x2013;1475. doi: 10.1093/bioinformatics/btu048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu048</ArticleId><ArticleId IdType="pmc">PMC4016707</ArticleId><ArticleId IdType="pubmed">24463181</ArticleId></ArticleIdList></Reference><Reference><Citation>Cradick TJ, Qiu P, Lee CM, Fine EJ, Bao G. COSMID: a web-based tool for identifying and validating CRISPR/Cas off-target sites. Mol. Ther. Nucleic Acids. 2014;3:e214. doi: 10.1038/mtna.2014.64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mtna.2014.64</ArticleId><ArticleId IdType="pmc">PMC4272406</ArticleId><ArticleId IdType="pubmed">25462530</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Bae S, Kim JS. Cas-Designer: a web-based tool for choice of CRISPR-Cas9 target sites. Bioinformatics. 2015;31:4014&#x2013;4016. doi: 10.1093/bioinformatics/btu786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu786</ArticleId><ArticleId IdType="pubmed">26358729</ArticleId></ArticleIdList></Reference><Reference><Citation>Pliatsika V, Rigoutsos I. &#x201c;Off-Spotter&#x201d;: very fast and exhaustive enumeration of genomic lookalikes for designing CRISPR/Cas guide RNAs. Biol. Direct. 2015;10:4. doi: 10.1186/s13062-015-0035-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13062-015-0035-z</ArticleId><ArticleId IdType="pmc">PMC4326336</ArticleId><ArticleId IdType="pubmed">25630343</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Bigio EH, Siddique T. Detection of protein aggregation in neurodegenerative diseases. Methods Mol. Biol. 2011;793:259&#x2013;272. doi: 10.1007/978-1-61779-328-8_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-61779-328-8_17</ArticleId><ArticleId IdType="pubmed">21913106</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, et al. Molecular dissection of ALS-associated toxicity of SOD1 in transgenic mice using an exon-fusion approach. Hum. Mol. Genet. 2008;17:2310&#x2013;2319. doi: 10.1093/hmg/ddn131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn131</ArticleId><ArticleId IdType="pmc">PMC2465800</ArticleId><ArticleId IdType="pubmed">18424447</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>